In the current study, silver chloride nanoparticles (AgClNPs) have been synthesized using the aqueous extract of Padina gymnospora and further characterized by Uv-visible spectroscopy, Fourier-transform infrared spectroscopy, X-ray powder diffraction, Scanning electron microscopy, energy dispersive spectroscopy, Transmission electron microscopy and Atomic force microscopy. The synthesized silver chloride nanoparticles were found to be mono-dispersed and spherical with an average size between 11.5 to 32.86 nm. The particles also showed a cytotoxic effect in a dose-dependent manner against MCF 7 cells (IC50 = 31.37 µg/mL). Besides, it showed the larvicidal activity against Aedes aegypti at a lower dose (3.92 µg/ml) than that of the aqueous extract (13.01 µg/ml). It also exhibited significant antimicrobial activity against selected bacterial and fungal pathogens. The synthesized silver chloride nanoparticles showed the best minimum inhibitory concentration (MIC) of 8 mg/L in Canadian Albicans, followed by vancomycin resistance Enterococcus feacasli (VREF) 32 mg/L. Furthermore, the toxicity assessment by haemolytic assay revealed that AgClNPs could be safe and also used for further investigation. Therefore, the synthesized silver chloride nanoparticles may be used as a therapeutic agent for breast cancer, antimicrobial agent and also to control the dengue vector as attributed to the presence of bioactive components.